Somnomed Limited

As of June 30, 2026, Somnomed Limited carries a market capitalization of 68.41M, placing it among publicly traded companies globally. Its enterprise value stands at 61.30M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Somnomed Limited's next confirmed earnings release is scheduled for February 26, 2027.

As of June 30, 2026, Somnomed Limited has 217.85M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 0.96, and the price-to-book ratio stands at 2.38.

As of June 30, 2026, Somnomed Limited trades at an EV/EBITDA multiple of 15.66 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.88 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 103.69 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 61.30M versus a market cap of 68.41M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Somnomed Limited maintains a current ratio of 1.67, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 11.51, indicating elevated leverage, while an interest coverage ratio of 107.68 demonstrates strong ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Somnomed Limited posted a negative return on equity (ROE) of -5.68, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -3.51, reflecting losses generated across the asset base. Inventory turnover of 4.47 indicates how many times Somnomed Limited sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Somnomed Limited recorded 1.33M in income tax expense. The company reported a pretax loss of -277,430.73 and -1.61M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 22, 2026, Somnomed Limited's stock has declined approximately 62.29% over the past 52 weeks. The 50-day moving average sits at 0.20, while the 200-day moving average is 0.31.

Over the twelve months ended June 30, 2026, Somnomed Limited generated 69.38M in revenue and converted that into -1.61M in net income, yielding earnings per share of -0.01. EBITDA reached 3.91M, while operating income came in at 591,206.09.

As of June 30, 2026, Somnomed Limited holds 10.41M in cash and equivalents against 3.31M in total debt, resulting in a net debt position of -10.16M. Total book value stands at 28.71M, with working capital of 9.50M providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Somnomed Limited posted a gross margin of 61.13, reflecting its pricing power and cost economics. The operating margin of 0.85 and net profit margin of -2.31 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Total shareholder yield reaches 1.30, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Somnomed Limited shareholders.

Somnomed Limited's most recent stock split took place on April 10, 2024.

As of June 30, 2026, Somnomed Limited has an Altman Z-Score of 2.90, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.